Neuroblastoma UK Grant round 2024 application is now closed.

Research funding opportunities

Neuroblastoma UK invites applications for UK or Republic of Ireland (ROI) led research that will benefit children with neuroblastoma every two years.

Our next Grant Round will be in 2026.

A wide range of basic and applied research applications will be considered for funding, from studies to understand the origin and development of neuroblastomas to research that aims to develop new therapeutic approaches, improve existing treatments or explore treatment synergies.

Research that aims to establish a “proof of principle” for further research will also be considered. Grants will be evaluated by peer review and by our Scientific Advisory Board before a decision is made by the Trustee Board.

Full details, support docs and application form

Research grant round 2024

Thanks to your kind donations, Neuroblastoma UK awarded five research grants in 2024 totalling £1.1 million. Our focus was to fund new innovative research into neuroblastoma. New therapeutic approaches, pathways to improve existing treatments and exploration of an MRNA vaccine are some of the projects to be funded in the 2024 grant round; with an emphasis on translational research which can be rapidly transferred from the lab bench to bedside.

Research grant round 2021

Thanks to your kind donations, Neuroblastoma UK awarded two research grants in 2021 totalling £683,477, with a focus on improving treatment for children with advanced stages of the disease.

Professor Louis Chesler will receive a research grant of £469,093, which includes a donation of £15,000 from charity Friends of Rosie. Professor Chesler’s research aims to develop blood-based biomarker tests for children with high-risk neuroblastoma, to help guide and monitor treatment.

Dr Mark Gaze will receive a research grant of £214,385 to develop a new type of targeted, radiotherapy using radioactive antibodies for children with high-risk neuroblastoma.

Research grant round 2018

Thanks to our generous supporters, we provided funding for nine new research studies in 2019, as part of our 2018 grant round, with a total funding of £1.177 million.

Research ranges from studies to understand the origin and development of neuroblastoma to research that aims to develop new therapeutic approaches or improve existing treatments.

Small Grant Applications

Neuroblastoma UK considers applications for small amounts (under £5,000) of funding for innovative neuroblastoma research throughout the year.

Our Small Grants programme helps researchers develop projects that aim to improve our understanding of how neuroblastomas develop. This funding may then lead to form larger grant applications for novel, more effective approaches to treatment.

Please read the Guidance Notes for Small Grant applications (doc) carefully and submit your application on the Small Grants Application Form (updated January 2021).

Conflict of Interest

Neuroblastoma UK makes every effort to ensure that its decisions are fair, objective and transparent.

For both external reviewers and members of the Scientific Advisory Board, a conflict of interest policy is in place to seek to avoid the involvement of individuals with a conflict of interest in relation to an application through its review process.

Code of Conduct

Reviewers have a right to expect that their comments will be treated in confidence by both Neuroblastoma UK’s staff, trustees and other members of a peer review group.

Applicants should not under any circumstances, directly approach members of the Scientific Advisory Board in connection with their (or another’s) research application.

Download our Conflict of Interest and Code of Conduct Policy (PDF)